Evidence for separate PGD2 and PGF2 alpha receptors in the canine mesenteric vascular bed
- PMID: 230544
- DOI: 10.1016/0090-6980(79)90107-2
Evidence for separate PGD2 and PGF2 alpha receptors in the canine mesenteric vascular bed
Abstract
Potential interactions between PGD2 and PGF2 alpha in the mesenteric and renal vascular beds were investigated in the anesthetized dog. Regional blood flows were measured with electromagnetic flow probes. PGD2, PGF2 alpha and Norepinephrine (NE) were injected as a bolus directly into the appropriate artery, and responses to these agents were obtained before, during and after infusion of either PGD2 or PGF2 alpha into the left ventricle. In each case, the infused prostaglandin caused vascular effects of its own. Left ventricular infusion of PGD2 reduced responses to local injections of PGD2 in the intestine, and a similar effect was observed for PGF2 alpha, suggesting significant receptor or receptor-like interactions for each of the prostanoids. However, systemic infusion of prostaglandin F2 alpha (20--100 ng/kg/min) had no effect on renal or mesenteric vascular responses to local injection of prostaglandin D2. Similarly, PGD2 administration (100 ng/kg/min) did not affect responses to PGF2 alpha in the intestine. The present results therefore suggest that these prostaglandins, i.e., D2 and F2 alpha, act through separate receptors in the mesenteric and renal vascular beds. In addition, increased prostaglandin F2 alpha levels produced by infusion of F2 alpha reduced mesenteric but not renal blood flow, suggesting that redistribution of cardiac output might participate in side effects often observed with clinical use of this prostaglandin, such as nausea and abdominal pain.
Similar articles
-
Evidence for separate PGD2 and PGF2 alpha receptors in the canine mesenteric vascular bed.Adv Prostaglandin Thromboxane Res. 1980;6:385-7. Adv Prostaglandin Thromboxane Res. 1980. PMID: 6247887 No abstract available.
-
Different responsiveness of a variety of isolated dog arteries to prostaglandin D2.Prostaglandins. 1982 Jan;23(1):99-112. doi: 10.1016/0090-6980(82)90026-0. Prostaglandins. 1982. PMID: 6950464
-
Actions of prostaglandins in peripheral vascular beds.Fed Proc. 1981 May 15;40(7):1987-90. Fed Proc. 1981. PMID: 7014257
-
Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved.Prostaglandins Leukot Med. 1984 Apr;14(1):153-9. doi: 10.1016/0262-1746(84)90034-9. Prostaglandins Leukot Med. 1984. PMID: 6328541
-
The biology and pharmacology of PGD2.Prostaglandins. 1988 Feb;35(2):277-300. doi: 10.1016/0090-6980(88)90093-7. Prostaglandins. 1988. PMID: 3283848 Review. No abstract available.
Cited by
-
Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues.Br J Pharmacol. 1985 Jun;85(2):367-75. doi: 10.1111/j.1476-5381.1985.tb08870.x. Br J Pharmacol. 1985. PMID: 2992661 Free PMC article.
-
Oral administration of carvedilol and prazosin inhibits the prostaglandin F2 alpha- and noradrenaline-induced contraction of human hand veins in vivo.Clin Investig. 1992;70 Suppl 1:S13-9. doi: 10.1007/BF00207606. Clin Investig. 1992. PMID: 1317234 Clinical Trial.
-
Hemodynamic and metabolic changes during stimulation of ileal motility.Dig Dis Sci. 1981 Dec;26(12):1069-77. doi: 10.1007/BF01295970. Dig Dis Sci. 1981. PMID: 7307853
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous